)
)
ReShape Lifesciences Investor Relations Material
Latest events
Q3 2024
ReShape Lifesciences
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from ReShape Lifesciences Inc
Access all reports
ReShape Lifesciences Inc., a medical device company, develops, manufactures, and markets ReShape Integrated System for the management and treatment of obesity and metabolic diseases. The company offers RHS Gastric Balloon System as a non-surgical alternative to reduce weight; RHI Single Balloon Combination, which is designed to provide a tool to manage diabetes; and RHI Dual Balloon Combination, which is designed to treat conditions associated with obesity such as hypertension, hyperlipidemia, type 2 diabetes mellitus, dyslipidemia and obstructive sleep apnea.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
RSLS
Country
🇺🇸 United States